Andrew Selwyn is a Cardiology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 264 publications with 23,963 citations (h-index 71); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Imaging of Plaque With Magnetic Resonance Imaging (MRI)
Sponsor: Brigham and Women's Hospital
- Rho Kinase in Patients With Atherosclerosis
Sponsor: Brigham and Women's Hospital
- The Effects of Atorvastatin in Patients With Atherosclerosis
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.6%Statin25.3%Atorvastatin Calcium72%Rosuvastatin Calcium28%Part D≥43 patientsBeta blocker18.8%Metoprolol Succinate90%Metoprolol Tartrate10%Part D<11 patients+ 7 more classes in this area
Blood & clotting
13.9%Factor Xa inhibitor9.9%Eliquis77%Xarelto23%Part D<11 patientsP2Y12 inhibitor4%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
5.6%Potassium supplement5.6%Potassium Chloride100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1986–2008 per NIH RePORTER. The latest:
- RHO-KINASE IN PATIENTS WITH ATHEROSCLEROSIS: EFFECTS OF STATINS
Brigham and Women'S Hospital
FY2008$2,189M01RR002635 - RHO-KINASE IN PATIENTS WITH ATHEROSCLEROSIS: EFFECTS OF STATINS
Brigham and Women'S Hospital
FY2007$14,669M01RR002635 - RHO-KINASE IN PATIENTS WITH ARTHEROSCLEROSIS: EFFECTS OF STATINS
Brigham and Women'S Hospital
FY2006$19,782M01RR002635
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy
Journal of the American College of Cardiology
2004 - Endothelial function, inflammation, and prognosis in cardiovascular disease
The American Journal of Medicine
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”